Effect of BMS-914392 on Pharmacokinetics of Metoprolol

NCT01211821 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: metoprolol
DRUG: BMS-914392

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]